Investigational Drug Information for Clenbuterol
✉ Email this page to a colleague
What is the development status for investigational drug Clenbuterol?
Clenbuterol is an investigational drug.
There have been 11 clinical trials for Clenbuterol.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2019.
The most common disease conditions in clinical trials are Glycogen Storage Disease Type II, Infarction, and Sclerosis. The leading clinical trial sponsors are Dwight Koeberl, M.D., Ph.D., University of Copenhagen, and Maastricht University.
There are six hundred and fifty-six US patents protecting this investigational drug and zero international patents.
Summary for Clenbuterol
| US Patents | 656 |
| International Patents | 13,518 |
| US Patent Applications | 3,693 |
| WIPO Patent Applications | 2,133 |
| Japanese Patent Applications | 880 |
| Clinical Trial Progress | Phase 2 (2019-06-01) |
| Vendors | 27 |
Recent Clinical Trials for Clenbuterol
| Title | Sponsor | Phase |
|---|---|---|
| A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy | Mario Negri Institute for Pharmacological Research | Phase 2 |
| A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy | Gianni Soraru | Phase 2 |
| Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans | Morten Hostrup, PhD | N/A |
Clinical Trial Summary for Clenbuterol
Top disease conditions for Clenbuterol
Top clinical trial sponsors for Clenbuterol
US Patents for Clenbuterol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Clenbuterol | ⤷ Sign Up | Compositions and methods for treating chronic inflammation and inflammatory diseases | Infirst Healthcare Limited (London, GB) | ⤷ Sign Up |
| Clenbuterol | ⤷ Sign Up | SARMs and method of use thereof | University of Tennessee Research Foundation (Knoxville, TN) | ⤷ Sign Up |
| Clenbuterol | ⤷ Sign Up | Inhalable pharmaceutical compositions | iCeutica Pty Ltd. (Iluka, WA, AU) | ⤷ Sign Up |
| Clenbuterol | ⤷ Sign Up | Powder filling processes | Adamis Pharmaceuticals Corporation (San Diego, CA) | ⤷ Sign Up |
| Clenbuterol | ⤷ Sign Up | Compounds | CHIESI FARMACEUTICI S.P.A. (Parma, IT) | ⤷ Sign Up |
| Clenbuterol | ⤷ Sign Up | Compositions and methods for treating psychiatric disorders | GOSFORTH CENTRE (HOLDINGS) PTY LTD. (Maroochydore, Queensland, AU) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Clenbuterol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Clenbuterol | Australia | AU2011322255 | 2030-10-29 | ⤷ Sign Up |
| Clenbuterol | Australia | AU2012213217 | 2030-10-29 | ⤷ Sign Up |
| Clenbuterol | Australia | AU2012213218 | 2030-10-29 | ⤷ Sign Up |
| Clenbuterol | Australia | AU2014204734 | 2030-10-29 | ⤷ Sign Up |
| Clenbuterol | Australia | AU2014204735 | 2030-10-29 | ⤷ Sign Up |
| Clenbuterol | Australia | AU2014204737 | 2030-10-29 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
